-
London police to extend use of live facial recognition, drones
-
Australia spy chief warns of Iran terror threat
-
Europe swelters under record-breaking heatwave
-
Heatwave-hit Europe must adapt healthcare: WHO
-
Iran says deal to end Mideast war 'declaration of US defeat'
-
Euclid telescope snaps best photo yet of Milky Way's heart
-
S.Korea chip giant SK hynix seeks $29 bn in Nasdaq listing: regulatory filing
-
French-German tank maker KNDS fires starting gun on mega-IPO
-
'Pragmatists' vs 'hardliners': Is Iran split over US deal?
-
Right-winger Fujimori poised to win Peru president runoff
-
H5 bird flu detected in second Australia state
-
Major power outage in France as Europe wilts under record heat
-
Brazil aim for last 32 as World Cup goes into hectic phase
-
Back in stork: returning birds bring joy to Croatian village
-
Necessity drives gold miners in DR Congo's Ebola epicentre
-
China premier urges AI governance to avoid 'losing control'
-
Japan PM heckled at WWII memorial
-
Colombia beat DR Congo 1-0 to reach World Cup knockouts
-
Hanoi residents mount silent protest over home demolitions
-
West Indies brace for Sri Lanka challenge as Da Silva returns
-
US Congress passes symbolic Iran war rebuke to Trump
-
Stokes urged to use curfew controversy as fuel to beat New Zealand
-
Bolivia's government is 'stoking a civil war,' ex-president Evo Morales tells AFP
-
Seoul bounces as Asian markets look to recover from rout
-
Fans in China put politics aside to cheer Japan at World Cup
-
North Korea's Kim unveils plans for 10,000-tonne warships, nuclear navy
-
Geopolitics and AI in spotlight at China's 'Summer Davos'
-
Ghosts of Gijon linger as new World Cup format encourages collusion
-
Race for robotaxi market arrives in London
-
Panama out of World Cup after defeat to Croatia
-
Moana Pasifika axed from Super Rugby after rescue talks fail
-
Wizards choose teenage talent Dybantsa with No.1 pick in NBA Draft
-
Golden Boot battle steals the show at World Cup
-
Tuchel insists England remain on course at World Cup despite Ghana draw
-
Red or green? For Brazil, the politics of World Cup kits matter
-
XCF Global Advances Toward Initial Renewable Diesel Production with Planned Transition to SAF Amid Global Fuel Market Volatility
-
Andes Health Mart Pharmacy Honored as IPC's 2026 Most Valuable Pharmacy
-
Empire Metals Limited Announces Completion of Sale of Eclipse Mining Lease
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 24
-
Thalia Therapeutics PLC Announces Acquisition and £2.75 Million Fundraise
-
AQP One Introduces BioBaseline(TM) as a Foundational Standard for Physiological Intelligence
-
Silver Range Expands Alamo Gold-Copper Target
-
Top 25* Firm Carr, Riggs & Ingram Continues Strategic Expansion in Texas
-
Bellingham rues England's 'second game fever' after Ghana draw
-
US Congress passes landmark housing affordability bill
-
Meta offers lower cost glasses as wearables competition heats up
-
Dream job: US soccer fans paid to watch every World Cup game
-
England left frustrated by Ghana in World Cup draw
-
Europe wilts under record heat as AC sales soar
-
Grieving Deschamps to miss France's final World Cup group game
Texas federal judge halts US approval of abortion pill
A conservative federal judge in the state of Texas halted US approval of the abortion pill mifepristone on Friday, but paused implementation for a week to give federal authorities time to appeal.
The suit against the Food and Drug Administration is the latest step in the campaign to win a total ban on abortion following a landmark Supreme Court ruling last year. It takes aim at a pill involved in 53 percent of all abortions in the United States, or more than half a million every year.
"FDA's approval of mifepristone is hereby STAYED," Judge Matthew Kacsmaryk wrote in his decision, adding that the court was also halting "applicability of this opinion and order for seven (7) days."
While the FDA has never been challenged like this before on its approval of a drug that has proven safe and effective, the plaintiffs -- a coalition of anti-abortion groups -- counted on being able to win a national freeze on distribution of mifepristone.
Presiding over the case in federal court in Amarillo, Texas is Kacsmaryk, who was appointed to the bench by Republican former president Donald Trump and confirmed by the Senate in 2019.
The judge is a conservative Christian with a personal history of opposition to abortion and a court record of favoring right-wing causes.
The case landed in his court via what critics call "judge-shopping," in which plaintiffs take legal action in a district where the judge has a history of rulings that support their case.
Federal judges in the United States have a right to issue rulings that carry national legal force.
Democratic politicians were quick to react on social media.
"This ruling opens a new door to politicizing medicine," New York Governor Kathy Hochul posted on Twitter. "Extremists will not stop at stripping away abortion rights."
Massachusetts Senator Elizabeth Warren posted that "because of today's lawless ruling, women could lose access to a safe and legal medication they've relied on for decades."
One component of a two-drug regimen used for medication abortion, mifepristone can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
While abortion care has halted in more than a dozen states after the Supreme Court overturned the long-established constitutional right last June, it is still legal in dozens more.
O.Brown--AT